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Abstract Representing the 3D structures of ligands in
virtual screenings via multi-conformer ensembles can be
computationally intensive, especially for compounds with a
large number of rotatable bonds. Thus, reducing the size of
multi-conformer databases and the number of query con-
formers, while simultaneously reproducing the bioactive
conformer with good accuracy, is of crucial interest. While
clustering and RMSD ﬁltering methods are employed in
existing conformer generators, the novelty of this workis the
inclusionofaclusteringscheme(NMRCLUST)thatdoesnot
require a user-deﬁned cut-off value. This algorithm simul-
taneouslyoptimizesthenumberandtheaveragespreadofthe
clusters. Here we describe and test four inter-dependent
approaches for selecting computer-generated conformers,
namely:OMEGA,NMRCLUST,RMSﬁlteringandaveraged-
RMS ﬁltering. The bioactive conformations of 65 selected
ligandswereextractedfromthecorrespondingprotein:ligand
complexes from the Protein Data Bank, including eight
ligands that adopted dissimilar bound conformations within
different receptors. We show that NMRCLUST can be
employed to further ﬁlter OMEGA-generated conformers
while maintaining biological relevance of the ensemble. It
was observed that NMRCLUST (containing on average 10
times fewer conformers per compound) performed nearly as
well as OMEGA, and both outperformed RMS ﬁltering and
averaged-RMS ﬁltering in terms of identifying the bioactive
conformations with excellent and good matches (0.5\
RMSD\1.0 A ˚). Furthermore, we propose thresholds for
OMEGA root-mean square ﬁltering depending on the num-
ber of rotors in a compound: 0.8, 1.0 and 1.4 for structures
with low (1–4), medium (5–9) and high (10–15) numbers of
rotatable bonds, respectively. The protocol employed is
general and can be applied to reduce the number of con-
formers in multi-conformer compound collections and alle-
viatethecomplexityofdownstreamdataprocessinginvirtual
screening experiments.
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Introduction
Ligand-based drug design (LBDD) approaches, such as
3D-similarity searches [1, 2], pharmacophore modeling [3,
4], and 3D-QSAR development [5–7], involve predicting
the bioactive conformations of drugs in the absence of a
structural model for the receptor. Typically, multiple con-
formations of potential drug molecules are generated via
random or systematic conformational searches in vacuum,
distance-dependent dielectric or implicit solvent [8, 9], and
employed to search for bioactive conformations. However,
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formational changes upon binding to receptors, do not bind
in their lowest energy solution- or gas-phase free states
[10–12] and are more extended in the bound state [13, 14].
Therefore, the success of LBDD relies heavily on the
ability of conformer generators to produce conformers
whose conformational space includes the bioactive state
(except in cases where methods are largely independent of
the precise ligand conformation) [15]. Because of the dif-
ference between bound and unbound states, another con-
sideration is how many unbound conformations should be
employed to contain a representative of the bioactive
conformation(s). The level of interest in addressing this
question is reﬂected in the number of studies that have been
undertaken either by testing existing conformer generators
with different protocols [9, 11–13, 16–22] or by developing
more efﬁcient conformational search algorithms [23–26].
The contribution of internal energy to the thermody-
namics of binding necessitates a good 3D representation of
the conformers. For example, a 1.4-kcal/mol increase in
conformational energy results in an approximately 10-fold
decrease in afﬁnity [27]. Furthermore, intramolecular
hydrogen bonding (due to its directionality) and electro-
statics (due to its sensitivity to distance) increase the com-
plexity of conformational search space, among others.
Therefore, the treatment of these interactions is crucial for
conformer generators, some of which include CAESAR
[24], OMEGA [28], ConfGen [29], CatConf [30], and sto-
chastic proximity embedding [31, 32], to cite a few. Having
generated the conformers the next step involves a judicious
selection of structures to be employed in further work
(ligand- or structure-based investigations). The most com-
mon strategies employed by some established conformer
generators comprise RMS ﬁltering [28, 29] and poling [30].
In addition RMS could also be used for post ﬁltration.
Studies to determine what metrics to employ in selecting
unbound conformers to represent a bioactive conformation
typically include energy- and geometry-based methods.
Alternatively, structural similarity and activity similarity
have been used together to derive putative bound confor-
mations [33]. Energy-based methods, on the other hand,
involve comparing the internal strain energies of the global
orlocalminimaofcomputer-generatedmodelswiththoseof
the bound conformer or a generated conformer that is geo-
metricallyverysimilartotheboundstate[9–11,16,34].The
energies are computed employing quantum–mechanical
methods or empirical force ﬁelds in different environments.
The energy-based methods are outside the scope of this
work; however, it sufﬁces to note that these methods have
resulted in cut-offs ranging from 0.5 [16] to 41.6 kcal/mol
[10], which truly illustrates the diversity present in the
energetics of ligand binding events. Thirdly, in geometric
approaches [10, 13, 18, 21] root-mean-squared deviations
(RMSD) are computed between the heavy atom positions of
computer-generated low energy conformers of a ligand and
those ofits bioactive conformer. Previously, conformational
differences were observed between bound and unbound
structures; however, in nine out of ten cases the bound and
free conformations displayed similarities in the positions of
key atoms involved in ligand recognition [21]. Utilizing 100
low energy conformers per ligand, Gu ¨nther et al. [18]
reproduced the bound states of ligands for 70% of the entire
datasetand90%ofthetimeforaveraged-sized(5.6rotatable
bonds) molecules with a similarity threshold of 1.0 A ˚.A ta
1.0-A ˚ cutoff, Auer et al. identiﬁed bioactive structures in
75% ofthe ligands studied [13],while the RMSDs ofatleast
86% of the ligands investigated by Kirchmair et al. were
within 2.0 A ˚ of the bioactive conformer [12].
These RMSDand energy ranges indicate that they cannot
be applied broadly, but only by simultaneously considering
the number of rotatable bonds of the ligand and the func-
tional form of the force ﬁeld or energy-based method. Given
that bioactive conformers span arange ofinternalenergies it
is reasonable to select conformers that cover this range,
while at the same time employing a cutoff that does not
result in an unmanageable number of conformers in a multi-
conformer database. Quantum mechanics methods are the
most rigorous; however, their computationally intensive
nature prohibits their application to a multi-conformer
database.Hence, the useoffaster but lessaccurate empirical
methods remains.
Our broad goal is to integrate objective ensemble clus-
tering strategies with established conformer generators in
order to select as few computer-generated conformers as
possible to represent the bioactive conformer(s) in a search
database, in an effort to minimize the complexity of down-
stream analyses of results. Ensemble clustering has been
implemented before using principal component analysis to
determine unique conformers from a collection of con-
formers [35]. Also, it was demonstrated earlier that con-
formational diversity could be achieved by including a
poling penalty function in the search algorithm, which
penalizes current conformers that are closely related to
pre-existing conformers [36]. The conformer generator
employed in this study, OMEGA [28], utilizes RMSD ﬁl-
tering to reduce conformer redundancy during the ﬁltration
step; nonetheless, the number of conformers generated can
potentially be reduced. Additional downstream or on-the-ﬂy
enhancements can be employed by clustering methods that
do not require user-deﬁned cut-off values to pare down the
number of conformers in large databases, for instance, the
hundreds of thousands of compounds typically found in
combinatorial libraries. In the current work, we employed
the NMRCLUST algorithm implemented in the Chimera
version 1.4.1 command line interface [37] as the extra step.
NMRCLUSTisnon-subjectivecomparedtootherclustering
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specify a maximum intra-cluster RMSD cutoff that is
directly linked to the number of clusters generated. In
practice this is convenient since knowledge of the full con-
formational landscape of a compound is generally not
knownapriori.In this work we show that further ﬁltering of
OMEGA-generated conformers with the NMRCLUST
algorithm produces a smaller number of structures that can
be employed to represent the conformational space of a
drug-like molecule, while at the same time maintaining
biological relevance of the ensemble.
Methods
The workﬂow employed in this study is illustrated in Fig. 1.
The bound conformations of the ligands were obtained from
their co-crystallized complexes in the Protein Data Bank
(PDB). These structures had been employed previously to
investigate the relative energies of the bound conformations
of drug-like molecules [16]. Two structures (1RO9 and
3CPA) were removed from the list, because of questionable
B-factors [16]. In addition, eight pairs of identical ligands
that crystallized in dissimilar conformations in different
receptorswere included. Asubsetof 65 ligands was selected
to represent the entire range of rotatable bonds reported for
some drug-like compounds (Tables 1, 4)[ 12]. Hydrogen
atoms were added to the crystal structures of the ligands
employingthe AddHtoolofChimeraversion 1.4.1[37],and
each ligand inspected visually for structural consistency.
The positions of hydrogen atoms were optimized, while the
heavy atoms were ﬁxed utilizing the default minimization
criteria in Chimera version 1.4.1 (100 steps, stepsize 0.02 A ˚,
update interval 10, Gasteiger charges). Finally, each struc-
ture was minimized in the Molecular Operating Environ-
ment version 2008.10 (MOE) program [38] employing
heavy-atom positional constraints that are related to atomic
B-factors and the temperatures at which the crystals were
solved. This treatment of the dataset was performed to take
into consideration high B-factors that can lead to inaccurate
ﬁtting of ligand atoms. Details of this approach have been
published elsewhere [16]. Brieﬂy, this method takes
advantage of the notion that atoms with low B-factors have
well-resolved electron densities, therefore, their positions
are well-deﬁned by the experimental coordinates and may
not require further adjustments. However, high B-factors
indicate high atomic mobility and positional uncertainties.
Thus, in minimizing the bioactive structures the positional
constraints are higher on atoms with well-deﬁned atomic
coordinates compared to those with poorly-deﬁned coordi-
nates. As a result atoms with low B-factors would be rela-
tively stationary, while the positions of atoms with high
B-factors would move presumably to their optimal positions.
(In this study superposing pre- and post-minimized bioactive
conformations did not lead to any signiﬁcant changes in
compound geometry, see the Results section and Table S1).
Additional factors, such as protein environment, explicit
solvent effects, etc. are not considered in this process.
Next, the computational 3D models were built from
scratch,andminimizedemployingtheMMFF94xforceﬁeld
and default parameters in MOE. Four conformer sets were
generated from these initial conformers. The ﬁrst set of
Extract the bioactive conformers 
from their complexes in the protein 
data bank. 
Build and minimize separate 
computer models of the ligands 
in MOE from scratch 
1). Add hydrogen atoms to the 
bioactive conformers.  
2). Optimize the positions of the 
hydrogen atoms while freezing 
those of the heavy atoms 
1). Generate multiple conformers for 
the ligands using recommended 
OMEGA settings (see Methods for 
details) 
2). Translate the conformers to the 
same coordinate frame of reference as 
their bioactive conformers using 
ROCS 
Cluster the multi-conformer ligands 
using the NMRCLUST algorithm 
and extract the representative 
structures from each cluster 
Minimize the extracted ligands 
using constraints that depend on 
the B-factors of the atoms. 
Compute the RMSD between each 
computer-generated structure and 
the prepared bioactive conformer
1). Generate a set of conformers by 
altering the rms value in OMEGA to 
generate similar numbers of 
conformers as the number of clusters 
determined by NMRCLUST 
2). Translate the conformers to the 
same coordinate frame of reference as 
their bioactive conformers using 
ROCS 
1). Generate another set of conformers 
using the averaged rms values in 
OMEGA for low, medium and high 
number of rotors (see Methods for 
details) 
2). Translate the conformers to the 
same coordinate frame of reference as 
their bioactive conformers using 
ROCS 
1 2 3
Fig. 1 The workﬂow employed in this study. For the goal of
comparing different tools in their ability to reproduce the conforma-
tion of ligands in their bound states, conformers generated by
OMEGA were subsequently clustered and the information in the
smaller number of cluster centers was compared to the information
contained in the original OMEGA output
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123conformers (omega) was generated utilizing default
OMEGA version 2.3.1 parameters except for the following:
rms = 0.4; ewindow = 25.0 kcal/mol, maxconfs = 500;
searchff = mmff94s_noestat. The initial number of con-
formers generated was 50,000, speciﬁed via the maxconfgen
parameter. The rms parameter sets a lower limit for ﬁltering
similar conformers; maxconfs determines the ﬁnal number
of conformers to be retained from the initial ensemble
requested via maxconfgen; the searchff speciﬁes the force
ﬁeld employed to compute internal energies during con-
former search; and ewindow sets an upper limit for retaining
the generated conformers. The incomplete force ﬁeld,
mmff94s_noestat, was employed in order to neglect intra-
moleculargas-phaseinteractionsthatcouldleadtocollapsed
conformations, given that bound conformers are generally
more extended than unbound conformers [13, 14]. The
OMEGA parameters were employed because they have
been shown to be optimal in terms of reproducing the bound
conformations of ligands [12]. In addition, the maxconfs
limit of 500 was set because the clustering algorithm scales
as O(n
2), see below. The OMEGA-generated conformers
were translated to the same coordinate frame of reference as
the bioactive conformer employing a rigid-body superposi-
tion with the ROCS version 2.3.1 program [39]. The second
Table 1 The protein data bank IDs from which the ligands were extracted, the number of rotatable bonds, the number of conformers
Ligand Rotors omega
a nmrclust
b rms
c rms_avg
d Ligand Rotors omega
a nmrclust
b rms
c rms_avg
d
1CIM 1 8 4 4 4 1UVT 8 500 57 66 253
1QPE 2 2 2 2 1 1YDT 8 500 44 52 121
1YDR 2 25 7 11 12 2CGR 8 500 55 68 66
2PCP 2 5 5 5 3 3ERT 8 500 92 102 8
1F4E 3 26 6 6 5 1M48 9 500 48 48 54
1FCX 3 111 21 23 27 1NHU 9 500 47 54 104
1H1P 3 378 47 50 44 1NHV 9 500 88 99 113
1H9U 3 32 5 8 8 2QWI 9 500 35 35 15
1 JSV 3 68 16 18 24 1K1 J 10 500 57 64 142
1BR6 4 79 16 20 23 1KV2 10 500 72 72 44
1DLR 4 109 16 17 19 1MQ6 10 500 62 66 76
1FCZ 4 135 19 20 24 7DFR 10 500 78 84 28
1L2S 4 34 7 7 8 1EZQ 11 500 68 69 88
2CSN 4 88 10 10 11 1FKG 11 500 78 84 92
1K7E 5 75 19 23 10 1K22 11 500 54 60 33
1KV1 5 38 6 8 6 1QBU 11 500 66 69 118
1QL9 5 500 54 60 198 1HFC 12 500 54 59 50
1YDS 5 319 22 22 11 1MNC 12 500 55 55 57
5STD 5 331 48 54 29 1OHR 12 500 44 44 47
1EVE 6 500 37 46 31 1UVS 12 500 58 60 83
1F0T 6 500 64 68 262 7EST 12 500 62 68 29
1H1S 6 500 61 69 88 1ELA 13 500 39 45 25
1HDQ 6 45 9 12 6 1GWX 13 500 110 120 274
1K7F 6 500 75 80 52 1HPV 13 500 41 47 115
1A42 7 500 63 67 33 1O86 13 500 33 34 27
1IF7 7 500 70 82 179 1F4G 14 500 49 49 35
1L8G 7 500 36 36 50 1HTF 15 500 58 59 149
1LQD 7 500 60 65 182 1MMB 15 500 37 37 63
966C 7 500 52 56 45 Average 7.7 366.8 43.8 47.7 65.0
The number of conformers generally increased with the number of rotors for each method
a Enumerated with recommended settings in OMEGA
Generated by:
b Clustering the OMEGA conformers employing the NMRCLUST algorithm
c Adjusting the rms parameter of OMEGA to generate similar numbers of conformers as the number of clusters identiﬁed by the NMRCLUST
algorithm
d Partitioning the dataset into low, medium and large numbers of rotatable bonds, averaging the rms values in each group and using the averaged
rms values
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generated conformers of each molecule using the NMRC-
LUST algorithm in the Chimera command line interface,
which employs the Kelley penalty function [40] to deter-
mine an optimal number of clusters. Utilizing the NMRC-
LUST algorithm avoids subjective inputs of pre-deﬁned
intra-cluster cut-offs or spreads, by selecting the number of
clusters that minimizes a penalty function during hierar-
chical clustering of an RMS distance matrix, D(i, j)
employing the average-linkage method. The average-link-
agemethod performed best forthistype ofstudiescompared
to single or complete linkage [40]. For each hierarchy a
penalty function is determined using the number of clusters
and the average spread of the clusters. The hierarchy that
gives the minimum value of the penalty function is selected
to represent the optimum number of clusters for the con-
former ensemble. Brieﬂy, a distance matrix consisting of
heavy-atom pairwise RMSDs for an ensemble of structures
is generated. Next, hierarchical clustering is performed with
the matrix using the average-linkage method:
distðm;nÞ¼
PX
i¼1
PY
j¼1 distði;jÞ
  
XY
for clusters m and n with X and Y members, respectively,
and dist(i, j) the RMS between the superimposed i and j
from m and n, respectively [40].
In the course of the clustering, the average spread is
determined at each stage using the spreads determined by:
[40]
spreadm ¼
PN
k¼1
PN
i¼1;i\k distði;kÞ
  
NðN   1Þ=2
for cluster m containing N members, with conformers i and
k; by deﬁnition, clusters that contain only one member
(singletons or N = 1) are excluded in the calculation of the
spread. The average spread is computed by: [40]
AvSpi ¼
Pcnumi
m¼1 spreadm
  
cnumi
where i is a given hierarchy, and cnumi the number of
clusters at that hierarchy. The average spreads are then
normalizedwith valuesbetween oneand(NT - 1),whereby
NT is the total number of structures in the ensemble as
follows: [40]
AvSpðnormÞi ¼
ðNT   2Þ
MaxðAvSpÞ MinðAvSpÞ
  
 ð AvSpi
  MinðAvSpÞÞ þ 1
Max(AvSp) and Min(AvSp) denote the maximum and
minimum average spreads, respectively, in the set across
all the stages of the clustering. This results in equal weights
in the average spreads and number of clusters in a penalty
function that is computed as the sum of the normalized
average spread at a given hierarchy and the corresponding
number of clusters (including singletons). The penalty
scores are then stored as a function of the number of
clusters and the average normalized spreads: [40]
Pi ¼ AvSpðnormÞi þ nclusti
The number of clusters that corresponds to the minimum
penalty score deﬁnes the cut-off for the ensemble. This cut-
off represents the stage wherein the clusters are as highly
populated as possible, while concurrently minimizing the
spread. After this analysis, a structure closest to the
centroid of each cluster is selected as the representative
structure. The third set of structures (rms) was generated by
altering the value of the rms parameter in OMEGA in order
to obtain a comparable number of conformers as the
number of representative structures identiﬁed by
NMRCLUST. Finally, the fourth set of structures
(rms_avg) was generated by partitioning the dataset in
terms of number of rotors: low, having between one and
four rotatable bonds; medium, possessing between ﬁve and
nine rotatable bonds; and high, with ten to 15 rotatable
bonds. The rms-ﬁltering cutoffs employed in set three for
the compounds in each category were averaged and
employed to generate conformers for each molecule in
the rms_avg set.
The RMSDs between the computer-generated structures
and their bioactive conformations were computed for each
multi-model ﬁle, utilizing the g_rms module of GRO-
MACS [41], and the RMSD statistics (average, standard
deviation, minimum and maximum values) were extracted
(see Table 2). Perl scripts were written for the automation
of the conformer generation, ROCS overlays, and RMSD
analyses procedures.
Results and discussions
The metric employed to assess deviations between the
computer-generated and bioactive conformers was the
RMSD between each pair of computed and experimental
structures. To improve the quality of the structures, the
bioactive conformers were reﬁned via energy minimiza-
tions taking into account positional uncertainties in the
experimental atomic coordinates via atomic B-factors.
Details are provided in the Methods section. It is con-
ceivable that these minimizations may signiﬁcantly alter
the conformations of the bioactive structures, though
minimizations of experimental structures in energy and
structural comparisons are not uncommon [16, 22]. In this
study superposing the pre- and post-minimized bioactive
J Comput Aided Mol Des (2010) 24:675–686 679
123conformations of each compound did not reveal any sig-
niﬁcant changes, Table S1.
For the computer-generated ensembles, the ﬁrst set
(omega) was employed as a performance reference as well
as the input ﬁle for subsequent clustering steps. It could
also be seen from this output whether the number of con-
formers generated with our OMEGA parameters actually
included the bioactive conformation in the ﬁrst place. The
second set (nmrclust) served to represent the conforma-
tional space of each molecule employing a smaller number
of conformers by clustering, with the aim of retaining the
bioactive conformation. The clustering approach employed
here does not require a priori knowledge of the desired
number of conformers, nor the maximum spread of dis-
tance cut-off to include structures in a cluster [40]. In the
third set of structures, the rms parameter of OMEGA was
adjusted for each compound to give a similar number of
conformers as obtained with the clustering method. This set
is intended to determine whether the clustering can be
avoided by simply modifying the rms ﬁltering value to
generate the desired number of conformers per molecule.
Lastly, a fourth set was constructed, named rms_avg.
Table 2 The minimum RMSDs between the bioactive conformations and the structures from the different computer-generated datasets
Ligand omega
a nmrclust
b rms
c rms_avg
d Ligand omega
a nmrclust
b rms
c rms_avg
d
1CIM 1.199 1.199 1.199 1.199 1UVT 1.315 1.329 1.296 1.315
1QPE 0.775 0.775 0.736 0.775 1YDT 1.104 1.154 1.154 1.154
1YDR 0.932 0.932 0.932 0.932 2CGR 1.087 1.087 1.659 1.613
2PCP 1.14 1.14 1.14 1.14 3ERT 0.384 0.569 0.472 0.738
1F4E 0.787 0.787 1.019 0.801 1M48 1.315 1.41 1.658 1.678
1FCX 0.761 0.81 0.871 0.81 1NHU 1.267 1.458 1.458 1.458
1H1P 0.493 0.681 0.708 0.708 1NHV 1.227 1.227 1.051 1.051
1H9U 0.766 1 0.772 0.772 2QWI 1.035 1.114 1.082 1.106
1 JSV 1.049 1.229 1.229 1.229 1K1 J 1.528 1.528 1.528 1.528
1BR6 0.6 0.751 0.6 0.6 1KV2 2.163 2.118 2.167 2.143
1DLR 0.164 0.164 0.599 0.599 1MQ6 0.991 1.177 1.197 1.23
1FCZ 1.083 1.105 1.114 1.114 7DFR 1.654 1.851 0.929 1.455
1L2S 0.533 0.738 1.033 0.935 1EZQ 0.871 0.953 1.054 1.116
2CSN 0.267 0.33 0.267 0.267 1FKG 1.639 1.66 1.118 1.413
1K7E 0.857 0.977 0.796 1.113 1K22 1.02 1.02 1.224 1.224
1KV1 0.435 0.435 0.63 0.8 1QBU 1.241 1.453 1.509 1.446
1QL9 0.836 1.018 1.064 0.98 1HFC 1.018 1.306 1.386 1.047
1YDS 0.951 1.058 1.008 1.065 1MNC 0.572 1.057 1.152 1.152
5STD 0.314 0.586 1.351 1.663 1OHR 1.174 1.298 1.298 1.298
1EVE 0.394 0.467 0.969 1.082 1UVS 1.483 1.541 1.541 1.541
1F0T 0.933 1.13 1.204 0.932 7EST 1.25 1.475 1.371 1.393
1H1S 0.839 0.839 1.153 1.231 1ELA 0.892 0.892 0.945 1.108
1HDQ 0.766 0.766 0.788 1.099 1GWX 1.375 1.375 1.375 1.375
1K7F 0.715 0.715 0.807 0.807 1HPV 1.094 1.094 1.733 1.136
1A42 0.907 0.951 0.937 1.012 1O86 0.885 1.05 1.205 1.205
1IF7 0.334 0.534 0.941 0.657 1F4G 1.266 1.304 1.367 1.367
1L8G 1.44 1.44 1.361 1.361 1HTF 1.284 1.395 1.395 1.256
1LQD 0.724 0.992 1.138 0.726 1MMB 0.915 0.915 0.915 0.915
966C 1.41 1.525 1.625 1.625 Average 0.973 1.068 1.127 1.131
It can be seen that the bioactive conformer is present when a smaller ensemble size is employed
a Enumerated with recommended settings in OMEGA
Generated by:
b Clustering the OMEGA conformers employing the NMRCLUST algorithm
c Adjusting the rms parameter of OMEGA to generate similar numbers of conformers as the number of clusters identiﬁed by the NMRCLUST
algorithm
d Partitioning the dataset into low, medium and large numbers of rotatable bonds, averaging the rms values in each group and using the averaged
rms values
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speciﬁc values could be employed during conformational
sampling depending on the number of rotors in a com-
pound. It is recognized that the last two sets of structures
(rms and rms_avg) include information derived from the
clustering dataset. As such it is presumed that the
NMRCLUST algorithm is an efﬁcient clustering approach.
The ligands employed in this work, the number of
rotatable bonds and the initial numbers of conformers
generated by OMEGA are presented in Table 1. The
number of clusters identiﬁed employing the NMRCLUST
algorithm, and the number of conformers generated by the
rms and rms_avg ﬁltering schemes are also shown. As
expected, [42] the number of conformers generally
increased with the number of rotors for each method. For
instance for two rotors the average number of conformers
was 10.67, 4.67, 6 and 5.33 for omega, nmrclust, rms and
rms_avg, respectively, compared to 500, 47.5, 48 and 106,
respectively, for ﬁfteen rotors.
As a way to account for the molecular size, the ratio
between the number of rotatable bonds and the total number
of bonds between the heavy atoms for each ligand was
determined.Thisratioisanindicationoftheﬂexibilityofthe
molecule. Lower values of this ratio indicate that the com-
pound is generally less ﬂexible, more unsaturated, with
cyclic substructures that may or may not be fused. Conse-
quently, its bioactive conformer can be determined with
relativeease.Thereverseistrueforhighervalues.Therewas
an overall increase in this ratio, visualized in Fig. 2 as the
black line-open circles, reﬂecting some of the challenges
encountered when utilizing conformer generators to
obtain a conformer that closely resembles the bioactive
conformation of highly ﬂexible compounds, in agreement
with previous studies [10, 12]. Also shown in Fig. 2, are the
average RMSDs computed between the conformers in each
computer-generatedmulti-conformerﬁleandtheirbioactive
conformer. The average RMSDs were statistically similar
across all four methods, and did not provide speciﬁc details
about the similarities between individual computer-gener-
ated conformers and their bioactive conformer.
To obtain a better indication of the occurrence of the
bioactive conformer among the computer-generated con-
formers the range of RMSD values was determined for each
ligandforthedifferentschemes.Thebinsandpopulationsof
the minimum RMSD values between each ligand and its
bioactive conformer for the four methods employed are
shown in Fig. 3. A tabular format of these data is given in
supplementary material Table S2. A classiﬁcation of RMSD
values between computer-generated and bound conformers
has been suggested before: [12]R M S D\0.5 indicates an
excellent match; 0.5 B RMSD\1.0 signiﬁes a good
match; 1.0 B RMSD\1.5 suggests an acceptable match;
1.5 B RMSD\2.0 is still acceptable; and RMSD C 2.0 is
unacceptable. The population distributions are color-coded
with black, spotted and gray representing the low, medium
and high number of rotor categories, respectively. Overall,
the RMSD distributions covered the entire range from
excellent to unacceptable, although the majority of the val-
ues occupied the good to acceptable limits (from 0.5 to 1.5
A ˚). It is worth pointing out that for ligands with high num-
bers of rotatable bonds (10–15) none of the datasets con-
tained a conformer that was in excellent agreement with the
bioactive conformer. This is most likely a reﬂection of
insufﬁcient numbers of conformers because of the difﬁculty
inexhaustivelysampling theconformationalspaceofhighly
ﬂexible molecules [42].
Comparing the four different sets of generated con-
formers in terms of getting the bound ligand structure
revealed some notable trends, Fig. 3. For RMSDs B 0.5 A ˚
the rankings were as follows: omega[nmrclust[rms
[rms_avg. The trend was similar for good reproduction,
except that rms = rms_avg. Given the observed trends for
excellent and good reproduction it is expected that the order
will be reversed for acceptable and still-acceptable ﬁts with
the rankings being rms_avg[rms[nmrclust[omega
and rms[rms_avg[nmrclust[omega, respectively.
That the trends were reversed for the latter RMSD ranges
simply indicates the greater number of compounds distrib-
uted in the ‘‘excellent’’ and ‘‘good’’ categories of the RMSD
ﬁts for omega and nmrclust, compared to rms and rms_avg.
It is interesting to note that nmrclust was better than rms in
termsof‘‘excellent’’and‘‘good’’ﬁts,giventhatrmsﬁltering
had at least as many structures as nmrclust.
Since the rms_avg set was derived from the rms set, it is
expected that the number of conformers generated in the
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Fig. 2 Average RMSDs and ﬂexibility for each compound for each
method employed. The order of the compounds is the same as in
Table 1; as the number of the compound increases the number of
rotatable bonds also increases. Thus, the left- and right-most abscissa
points have one and ﬁfteen rotors, respectively. It can be seen that the
average RMSD and ﬂexibility increase with the number of rotors
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123rms_avg set would differ from the number of conformers
from the rms set; in fact, only in few cases such as 1CIM
and 1H9U were the number of conformers from these two
sets identical (Table 1). It was hypothesized that ligands
with more conformers in the rms_avg set than in the rms
set would be more likely to capture the bioactive confor-
mation, while the reversed would be true for ligands with a
smaller number of conformers. The overall comparison of
the number of conformers and the differences between
minimum RMSDs to the bioactive conformation for the
rms_avg and rms sets are shown in Fig. 4. The horizontal
axis represents conformer differences (rms—rms_avg),
while the vertical axis represents differences in minimum
RMSD (rms_avg—rms). The quadrants depict the dataset
as follows: lower-left, rms has less conformers and worse
representation of the bioactive conformers; upper-left, rms
has less conformers and better representation of the bio-
active conformers; lower-right, rms has more conformers
and worse representation of the bioactive conformers;
upper-right, rms has more conformers and better repre-
sentation of the bioactive conformers. It is expected that no
data points populate the upper-left and lower-right quad-
rants of this plot. The few cases falling into these quadrants
Fig. 3 Distributions of the minimum RMSDs (x) between each
ligand and its bioactive conformer for the four methods employed.
The qualitative descriptions are as follows: x\0.5 = excellent;
0.5 B x\1.0 = good; 1.0 B x\1.5 = acceptable; 1.5 B x\2.0
= still acceptable; x C 2.0 = unacceptable. The numbers above each
column represent populations within each RMSD range. The bars are
color-coded to indicate the occurrence of rotor categories. Black:
Low; Spotted: medium; Gray: High number of rotors
Fig. 4 Differences in the number of conformers between the rms_avg
and rms ﬁltering with respect to RMSD differences between the same
sets. The horizontal and vertical axes represent differences in the
number of conformers and RMSDs, respectively. Sized by increased
ﬂexibility. Black circles indicate ligands whose RMSDs were in
different ranges of the qualitative categories. The relatively small
number of these bold entries may explain why rms_avg and rms
ﬁltering performed very similar in the classiﬁcation made in Fig. 3
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123have either a small difference in the number of conformers
or a small difference in the minimum RMSD (rms_avg—
rms). Black circles (10 data points) represent ligands that
were classiﬁed into different categories in the qualitative
classiﬁcation of Fig. 3. The relatively few number of these
highlighted entries may explain why the rms_avg and rms
ﬁltering methods performed equally well in the classiﬁca-
tion presented in Fig. 3. Interestingly, increasing the
number of conformers did not ensure better ﬁts; in fact
some cases (far left) provided at best the same performance
(the difference in minimum RMSD is close to zero).
The statistics for the number of conformers and mini-
mum RMSD values generated by each method are pre-
sented in Table 3. It is demonstrated that employing a
smaller number of conformers in nmrclust, rms or rms_avg
we were able to get equal overall performances (56/57
acceptable RMSDs) from these methods. However,
whenever possible nmrclust would be the recommended
approach given that rms_avg was derived from rms and
will involve the cumbersome adjustments of individual rms
cutoffs for compounds in a large database. The rms_avg
values of 0.76, 1.01 and 1.39 for small, medium and large
number of rotors, respectively, derived in this study may
serve as guidelines in OMEGA for these categories of
compounds.
In addition, eight ligands adopting different bioactive
conformations in different complexes were included,
Table 4. The aim was to test whether the methods could
sample multiple bioactive conformations for the same
ligand. Generally, except for the kanamycin (KAN) and
FAD ligands the omega, nmrclust, rms and rms_avg
methods sampled both bioactive conformers within
acceptable limits (RMSD\2.0 A ˚). For the KAN case, the
methods sampled the bound conformation reasonably in at
least one complex. In the ﬁnal case (FAD in 1A8P and
1B2R), while rms did not capture the bound conformation
of the ligand, it was sampled at least once by omega,
nmrclust and rms_avg ﬁltering. It is worth pointing out that
when the rms_avg value was employed in OMEGA for
ligand FAD the number of conformers retained was 500,
similar to the number generated by omega, Table 4. For
FAD in 1A8P, rms_avg identiﬁed the same closest con-
former as omega. However, for 1B2R rms_avg sampled a
conformer that better reproduced the bioactive conformer
compared to omega. Also worth mentioning are cases
wherein a small number of conformers exhibited a better
representation of the bioactive conformer, comparing
omega and rms_avg. These include: ADP in 1HW8;
kanamycin in 1L8T; FAD in 1B2R; IM1 in 1TCW. (See
1H1P and 2CSN in Table 2). Although small in number,
these cases indicate that different conformers are being
sampled and that more than 500 conformers should be
considered, especially for highly ﬂexible molecules. The
overall performances of the methods were omega (88%),
nmrclust (88%), rms (81%) and rms_avg (94%). The sta-
tistics of the number of conformers and minimum RMSDs
indicate, once more, that a smaller number of ensembles
may be utilized to capture the bioactive conformer for this
set of ligands.
Employing a predictive model it has been hypothesized
that for small RMSD ﬁltering values and large numbers of
rotors the number of conformers required to exhaustively
cover the conformational space ranges from the hundreds
to hundreds of thousands [42]. This suggests that increas-
ing the likelihood of incorporating a bioactive conformer
during the conformer generation stage in ligand-based
methods could result in huge computational costs during
the screening stage. It is worth noting that there are some
instances wherein it has been stated [43] and demonstrated
[22] that the determination of a bioactive conformation or
number of query conformers employed does not improve
the performance of a 3D shape-based method such as
ROCS in recovering active compounds during virtual
screenings. This attests to the conformer generating
Table 3 Statistics for the number of conformers and minimum RMSD obtained by the four methods utilized
L95 Mean U95 Standard deviation
Rotors 6.74 7.719 8.699 3.774
Number of conformers omega 314.67 366.807 418.944 200.833
nmrclust 37.136 43.825 50.514 25.766
rms 40.435 47.684 54.934 27.925
rms_avg 47.36 64.982 82.605 67.881
Minimum RMSD (Angstroms, A ˚) omega 0.871 0.973 1.074 0.386
nmrclust 0.971 1.068 1.166 0.371
rms 1.038 1.127 1.216 0.338
rms_avg 1.045 1.131 1.218 0.327
L95 and U95 Lower and upper 95% conﬁdence interval of the mean, respectively
J Comput Aided Mol Des (2010) 24:675–686 683
123strengths of OMEGA, and the ability of ROCS to score the
compounds correctly even though the conformation may
not represent the bound state. However, in cases such as
pharmacophore modeling [18] and molecular-ﬁeld-based
similarity analysis [35] where the description of ligand
features complementary to an active site is crucial, an
accurate representation of the bound conformation is still
of utmost importance. Therefore, it would be computa-
tionally efﬁcient to reduce the number of conformers per
compound in a database, while still retaining the bioactive
conformer.
In a previous study, 10 conformers were recommended
[18] for averaged-sized molecules, while 50 conformers
have also been proposed for screening databases containing
several million compounds [12]. The goal of the current
work was to produce the least number of computer-gen-
erated structures, while still including the bioactive con-
former. Our results reﬂected this possibility, demonstrated
by the four conformer sets exhibiting acceptable repre-
sentations (RMSD\2.0 A ˚) of their bound conformations
in 56/57 (98%) instances.
The conformational overlap between the bound ligands
and the computer generated conformers is shown in Fig. 5
for the ligand with PDB ID 1MMB as an example. This
representation provides a qualitative view of how the
methods are performing in terms of sampling the bioactive
conformer. The generation of several structures dissimilar
to the bound conformer is observed. More importantly, the
bioactive conformer is captured, using a smaller number of
computer generated structures.
Table 4 The PDB structures employed for ligands present in dissimilar bound conformations in different receptors
Name
a Rotors
b RMSD differences
c
(Angstroms, A ˚)
RMSD pre/post-
minimization
d
(Angstroms, A ˚)
Number of conformers Minimum RMSD (Angstroms, A ˚)
omega
e nmrclust
f rms
g rms_avg
h omega
e nmrclust
f rms
g rms_avg
h
pbn_1TNI 4 1.386 0.44 39 8 9 7 0.48 0.664 0.48 0.48
pbn_1UTP 4 0.312 39 8 9 7 0.507 0.63 0.761 0.761
pt1_1BR6 4 2.107 0.308 78 15 15 19 0.613 1.121 0.794 0.794
pt1_1TX0 4 0.513 78 15 15 19 0.894 1.112 1.107 0.966
adp_13PK 6 2.193 1.134 500 65 68 180 1.132 1.154 1.192 1.192
adp_1HW8 6 0.862 500 65 68 180 1.435 1.486 1.441 1.363
kan_1KNY 6 2.248 0.709 500 41 45 70 1.855 1.855 2.039 2.039
kan_1L8T 6 0.626 500 41 45 70 2.026 2.026 1.764 1.815
i84_1EKO 8 1.369 0.519 500 62 69 50 1.124 1.149 1.217 1.609
i84_1EL3 8 0.383 500 62 69 50 0.891 0.947 0.962 0.997
fad_1A8P 13 2.851 0.656 500 40 48 500 1.634 1.746 2.288 1.634
fad_1B2R 13 0.605 500 40 48 500 2.116 2.363 2.169 1.574
acd_1ADL 14 1.859 0.667 500 64 69 148 1.081 1.081 1.081 1.081
acd_1CVU 14 0.57 500 64 69 148 1.306 1.532 1.494 1.435
im1_1SBG 16 3.306 0.357 500 68 75 75 1.576 1.595 1.76 1.76
im1_1TCW 16 0.414 500 68 75 75 1.732 1.732 1.665 1.665
L95 6.422 1.607 0.452 284.277 33.242 36.545 48.531 0.997 1.128 1.106 1.087
Mean 8.875 2.165 0.567 389.625 45.375 49.750 131.125 1.275 1.387 1.388 1.323
U95 11.328 2.723 0.683 494.973 57.507 62.954 213.719 1.554 1.646 1.671 1.558
Standard
deviation
4.60 0.67 0.22 197.70 22.77 24.78 155.00 0.52 0.49 0.53 0.44
The statistics of the data are shown in the last four rows of the table
a The name of the ligands and protein databank IDs are represented by the ﬁrst three and last four alphanumeric characters, respectively
b The number of rotatable bonds in the ligands
c RMSDs between the bound conformations of the same ligand in the two receptors selected
d The RMSDs between the minimized and unminimized bound ligand conformation. More details are presented in the Methods section
e Enumerated with recommended settings in OMEGA
Generated by:
f Clustering the OMEGA conformers employing the NMRCLUST algorithm
g Adjusting the rms parameter of OMEGA to generate similar numbers of conformers as the number of clusters identiﬁed by the NMRCLUST
algorithm
h Partitioning the dataset into low, medium and large numbers of rotatable bonds, averaging the rms values in each group and using the averaged
rms values. L95 and U95 are the lower and upper 95% conﬁdence interval of the mean, respectively
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Ensemble conformer clustering implemented using the
NMRCLUST algorithm has here been employed to deter-
mine the extent to which clustering of computer-generated
conformers reduces ensemble size, while still retaining the
bioactive conformation. This approach relies on the ability
of the conformer generator, in this case OMEGA 2.3.1, to
generate the bioactive conformation in the ﬁrst place.
Analysis of the minimum RMSD values between the bio-
active and the computer-generated ligands indicated that
the presence of more conformers in the ensemble increased
the probability of including the bound conformation. Even
though downsizing the number of generated conformers by
clustering may result in a potential loss of bioactive con-
formers, we showed that this approach successfully
reproduced acceptable bound ligand conformations 56 out
of 57 of the cases. In addition, OMEGA 2.3.1 sampled
satisfactorily different bound conformations for the same
ligand in different receptors. In terms of ‘‘excellent’’ and
‘‘good’’ representations, ensemble clustering performed
closest to the reference method (omega) compared to the
two RSMD ﬁltering methods employed here. Therefore, by
using this clustering method we showed that a smaller
number of conformers was sufﬁcient to capture the bio-
active conformers of the ligands. It remains to be deter-
mined how multiple conformers derived from other
conformer generators will perform. For combinatorial
libraries that range from hundreds of thousands to millions
of compounds such an approach may be applied to reduce
the number of conformers per ligand by performing on-the-
ﬂy clustering, thus allowing less intensive virtual screening
campaigns.
Supporting information available
The RMSDs between pre- and post-minimized bioactive
conformers and the distribution of the minimum RMSDs
relative to the bioactive structures. The experimental and
computer-generated coordinates of the ligands employed in
this work.
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